Cephalomedullary nails vs extramedullary implants: Mortality at 12 months
Cephalomedullary nails showed no clear difference in mortality at 12 months compared with extramedullary implants (moderate certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Cephalomedullary nails vs extramedullary implants Mortality at 12 months · older adults with stable or unstable extracapsular hip fractures Cephalomedullary nails showed no clear difference in mortality at 12 months compared with extramedullary implants (moderate certainty). Cephalomedullary nails versus extramedullary implants for extracapsular hip fractures in older adults (2022) · Cochrane Headline outcomes only | RR 0.99 [0.9, 1.08] | 47 studies · 7618 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Cephalomedullary nails versus extramedullary implants for extracapsular hip fractures in older adults 2022 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.